Inactive Instrument

Calendar Catalyst Biosciences Inc Nasdaq

Equities

US14888D1090

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI
2023	Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	CI

Chart calendar Catalyst Biosciences Inc

be7053aef0b4e07f03753f94d1a3873.PlDWWP5cnPZ8_iyVsqArKEL1KZ3YRACenLAckTlgjX0.UGS-GskX0psysUP_1sNzQSOsWcLqDmWpysFL01xNvTtwZrc3smnWwirTFA~8dc8339bdb460cd8824cb4bbec393805

Upcoming events on Catalyst Biosciences Inc

No events available

Past events on Catalyst Biosciences Inc

09/03/2023	Q4 2022 Earnings Release (Projected)
13/01/2023	Ex-dividend day
27/12/2022 06:30 pm	Catalyst Biosciences Inc and GNI Group Ltd Merger Call
21/09/2022	Ex-dividend day
16/08/2022 01:35 am	Interim 2022 Earnings Release
15/08/2022 08:30 pm	Annual General Meeting
09/05/2022 06:00 pm	Q1 2022 Earnings Release
31/03/2022 05:30 pm	FY 2021 Earnings Release
05/01/2022	LifeSci Partners Corporate Access Event
19/11/2021 12:24 am	Piper Sandler Virtual Healthcare Conference
12/11/2021 07:00 pm	Q3 2021 Earnings Call
12/11/2021 05:30 pm	Q3 2021 Earnings Release
28/10/2021	American Society for Biochemistry and Molecular Biology Meeting
26/10/2021	Complement based Drug Development Summit
29/09/2021 07:30 pm	Cantor Fitzgerald Global Healthcare Conference
15/09/2021 10:30 pm	Investor Meeting - Fireside Chat
05/08/2021 05:30 pm	Interim 2021 Earnings Release
19/07/2021 09:30 pm	R&D Day
19/07/2021	International Society on Thrombosis and Haemostatis Virtual Congress - Subcutaneous Marzeptacog Alfa
19/07/2021	International Society on Thrombosis and Haemostatis Virtual Congress - Dose Selection of Marzeptacog

Annual results

Fiscal Period	December	2018	2019	2020	2021	2022
Net sales Million USD	Released Forecast Spread	0,01 0,30 -98%	0,00 0,00 -	20,9 19,0 10.25%	7,34 5,15 42.54%	0,79 0,79 0%
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-33,8 -32,8 -3.12%	-57,3 -58,1 1.42%	-57,4 -58,9 2.6%	-87,9 -89,0 1.26%	-30,4 -29,7 -2.33%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00 0,00 -	-55,2 -55,6 0.76%	-56,2 -57,9 2.87%	-87,9 -89,0 1.25%	-7,89 28,2 -128%
Net income Million USD	Released Forecast Spread	-30,1 -29,8 -0.86%	-55,2 -56,3 1.99%	-56,2 -57,9 2.87%	-87,9 -89,0 1.25%	-8,24 28,2 -129.23%
EPS USD	Released Forecast Spread	-40,2 -39,9 -0.75%	-69,0 -68,0 -1.47%	-43,9 -40,0 -9.88%	-43,0 -42,8 -0.47%	-3,90 13,5 -128.89%
Announcement Date		07/03/19	20/02/20	04/03/21	31/03/22	30/03/23

Quarterly results

Fiscal Period	December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3
Net sales Million USD	Released Forecast Spread	2,30 0,50 359.8%	2,44 0,25 876%	0,79 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.25%	-14,7 -15,6 5.96%	-5,72 -6,91 17.25%	-5,17 -3,25 -58.86%	-4,83 -4,13 -16.74%	0,18 -2,68 106.65%	-2,54 -2,54 0.04%	-1,62 -2,08 22.05%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.19%	-14,5 -15,1 3.65%	51,6 -6,82 857.18%	-4,88 -3,06 -59.4%	-40,1 -4,02 -898.41%	0,27 -2,51 110.9%	-2,47 -2,48 0.52%	-1,58 -2,03 22.36%
Net income Million USD	Released Forecast Spread	-25,2 -20,6 -22.36%	-20,3 -21,4 5.19%	-14,5 -15,1 3.65%	51,6 -6,82 857.18%	-4,88 -3,06 -59.4%	-40,5	0,26 -2,51 110.34%	-2,47 -2,48 0.44%	-1,58 -2,03 22.36%
EPS USD	Released Forecast Spread	-12,0 -9,95 -20.6%	-9,75 -9,55 -2.09%	-6,90 -6,60 -4.55%	24,6 -3,30 845.45%	-2,40 -1,50 -60%	-19,2	0,15 -1,05 114.29%	-1,05 -1,05 0%	-0,60 -0,75 20%
Announcement Date		12/11/21	31/03/22	09/05/22	15/08/22	14/11/22	30/03/23	15/05/23	14/08/23	26/10/23

Upcoming sector events for Catalyst Biosciences Inc

More events